These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27086263)

  • 1. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease.
    Ricciardi L; Espay KJ; Krikorian R; Fasano A; Espay AJ
    Parkinsonism Relat Disord; 2016 Jul; 28():152-4. PubMed ID: 27086263
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease.
    Rosenthal SH; Fenton ML; Harnett DS
    Gen Hosp Psychiatry; 1992 Jul; 14(4):285-6. PubMed ID: 1505751
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of clozapine in Brazilian patients with Parkinson's disease.
    Gomide L; Kummer A; Cardoso F; Teixeira AL
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):611-4. PubMed ID: 18949249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to: Dopamine dysregulation syndrome and psychosis in 24-h intestinal levodopa infusion for Parkinson's disease.
    Ricciardi L; Fasano A; Espay AJ
    Parkinsonism Relat Disord; 2016 Oct; 31():143. PubMed ID: 27421951
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine in the treatment of psychosis in Parkinson's disease.
    Friedman JH; Lannon MC
    Neurology; 1989 Sep; 39(9):1219-21. PubMed ID: 2771073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic dilemma: psychosis and Parkinson's disease.
    Damecour CL; Turcotte JR
    Can J Psychiatry; 1995 Dec; 40(10):640-1. PubMed ID: 8681265
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.